- Cefuroxime 125mg/5ml oral suspension
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Cefuroxime 125mg/5ml oral suspension | Start Date 02-11-2002 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J01DC02
BNF | Start Date | End Date |
---|---|---|
Current BNF 05010201 | Start Date 04-04-2022 | End Date |
Previous BNF 05010201 | Start Date 06-03-2009 | End Date 03-04-2022 |
Previous BNF 05010200 | Start Date 01-02-2005 | End Date 05-03-2009 |
Code | Start Date | End Date |
---|---|---|
41945811000001104 | 09-06-2023 | |
323872003 | 02-11-2002 | 08-06-2023 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Cefuroxime axetil | Based on Base Substance | Cefuroxime | 25 mg | 1 ml |
Name
Cefuroxime axetil
Basis of strength description
Based on Base Substance
BOSS
Cefuroxime
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
1
Parent Products
-
VTMCefuroxime
-
VMP(Current) Cefuroxime 125mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
70 ml | 520 | Part VIIIA Category C |